We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Programmable DNA Nanosystem Designed for Low Cost Molecular Detection

By LabMedica International staff writers
Posted on 05 Jul 2016
Based in a novel way on the self-assembly forces between DNA complementary strands, researcher have developed programmable nanosystem that has now been applied in a proof-of-principle study on Ebola virus diagnosis potential.

The nanomachine is based on “the magic of how DNA works,” said Erik R. More...
Henderson, professor, Iowa State University (Ames, IO, USA). Prof. Henderson and former student Dr. Divita Mathur developed the system and its first application: genetic detection of Ebola virus. Such a machine would prove valuable in the developing world, where access to diagnostic medical equipment can be rare. This nanotechnology could be fabricated cheaply and deployed easily. In conjunction with a smartphone app, it could be used independently of traditional medical facilities to detect Ebola or other pathogens and diseases.

The trick lies in understanding the rules that govern how DNA works, said Prof. Henderson, “It’s possible to exploit that rule set in a way that creates advantages for medicine and biotechnology.” The researchers harnessed DNA hybridization forces so that the components of the nanomachines, once added to water and then heated and cooled, find each other and assemble correctly without further effort from the individual deploying the machines.

More technically, they harnessed the difference in persistence length (“rigidity”) of single-stranded and double-stranded DNA to elicit a defined physical state change in a self-assembling DNA nanosystem, a platform they call OPTIMuS (Oligo-Propelled Technology for Interrogating Molecular Systems). This inducible state change can be used to interrogate user-programmed molecular interactions within OPTIMuS. In this study they showed how OPTIMuS can be used to detect a soluble target molecule and assess the relative strength of a non-covalent (base stacking) molecular interaction. They employed an embedded photonic system that tests for the presence of the target molecules, where upon detection the photonic system flashes a light, which can be read with a fluorometer.

This sort of technology could be modified to detect other pathogens and other kinds of molecules. Prof. Henderson also envisions development of similar nanomachines that would encapsulate medication for targeted delivery.

The study, by Mathur D & Henderson ER, was published online June 7, 2016, in the journal Scientific Reports.

Related Links:
Iowa State University


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.